Sprague John M

Chief Financial Officer at T2 Biosystems, Inc.

Sold, on record
$16k
Dollars the filings state
Form 4 sales
3
Latest Feb 28, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale T2 Biosystems, Inc.Plan not stated
    Feb 24, 2020 2020

    Sold 4,166 shares at $0.82 ($3k)

    Sprague John M, Chief Financial Officer

    Sold 15.8% of holdings ($22k position)22,222 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale T2 Biosystems, Inc.Plan not stated
    Feb 23, 2021 +365 days

    Sold 5,250 shares at $2.04 ($11k)

    Sprague John M, Chief Financial Officer

    Sold 12.9% of holdings ($83k position)35,485 shares leftFiling

  3. 3 Form 4 sale T2 Biosystems, Inc.Unusual
    Feb 28, 2023 +735 days

    Sold 2,693 shares at $0.62 ($2k)

    Sprague John M, Chief Financial Officer

    Sold 27% of holdings ($6k position)7,268 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Sprague John M
Source
Feb 28, 2023Mar 9, 2023T2 Biosystems, Inc.Chief Financial OfficerForm 4 sale2,693$2k27.0%UnusualSEC
Feb 23, 2021Feb 23, 2021T2 Biosystems, Inc.Chief Financial OfficerForm 4 sale5,250$11k12.9%Plan not statedSEC
Feb 24, 2020Mar 3, 2020T2 Biosystems, Inc.Chief Financial OfficerForm 4 sale4,166$3k15.8%Plan not statedSEC